Evidence map›Paper›PMID 30354259›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2018

Impact of miRNA in Atherosclerosis.

Yao Lu, Tanuja Thavarajah, Wenduo Gu, Jingjing Cai, Qingbo Xu

Abstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed.

  1. Review
  2. The miR-2110/Biochemistry and biophysics reports · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Epigenetic Mechanisms in Heart Diseases.Reviews in cardiovascular medicine · 2025
    Review
  11. Article
  12. Article
  13. Connecting the Dots: How MicroRNAs Link Asthma and Atherosclerosis.International journal of molecular sciences · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Atherosclerosis: A Comprehensive Review of Molecular Factors and Mechanisms.International journal of molecular sciences · 2025
    Review
  19. Article
  20. Review

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yao LuFrom the Center of Clinical Pharmacology (Y.L.).
Tanuja ThavarajahSchool of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre, United Kingdom (T.T., W.G., Q.X.).
Wenduo GuSchool of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre, United Kingdom (T.T., W.G., Q.X.).
Jingjing CaiDepartment of Cardiology (J.C., Q.X.), Third Xiangya Hospital, Central South University, Changsha, China.
Qingbo XuDepartment of Cardiology (J.C., Q.X.), Third Xiangya Hospital, Central South University, Changsha, China.

Funding

British Heart Foundation CH/06/001/20110British Heart Foundation RG/14/6/31144
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAtherosclerosisCell DifferentiationEndothelial CellsHumansMacrophagesMicroRNAsMyocytes, Smooth MuscleOrganelle BiogenesisMicroRNAsatherosclerosisendothelial cellsmicroRNAsmuscle, smoothvascular diseases

Identifiers

PMID30354259
PMCPMC6795547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.